Score Big On Top Line Growth Stocks

A company that can continue to grow sales is creating value for its shareholders. However, strong top line growth isn’t the only sign of a winner. To help find some potential stock picks, we screened for the below criteria:

- Sales growth over past 5 years over 30%

- Sales growth quarter over quarter over 30%

- Return on assets over 10%

- Return on equity over 30%

We wanted to make sure that these companies were combining above average sales growth with an efficient use of their assets and equity in generating returns. It should be noted that increased sales at these types of rates are difficult to maintain and should be monitored closely quarter to quarter. Screening for the above criteria produced the list below:

Analyze These Ideas: Access a performance overview for all stocks in the list

1. The Carlyle Group LP (CG): A global alternative asset management firm. It conducts its operations through four segments: Corporate Private Equity, Real Assets, Global Market Strategies and Fund of Funds Solutions. Market cap at $8.04B, most recent closing price at $26.39.Sales past 5Y = 50.86% Sales Q/Q = 1540.44% ROA = 10.73% ROE = 34.54%

2. C&J Energy Services, Inc. (CJES): C&J Energy Services, Inc., through its wholly-owned subsidiary, C&J Spec-Rent Services, Inc., provides specialty equipment services for oil and natural gas exploration and production companies in the Texas, Louisiana, and Oklahoma regions of the United States. Market cap at $1.16B, most recent closing price at $21.95.Sales past 5Y = 92.40% Sales Q/Q = 34.39% ROA = 27.68% ROE = 45.65%

3. Francesca’s Holdings Corporation (FRAN): Operates a chain of retail boutiques in the United States. Market cap at $1.19B, most recent closing price at $27.02.Sales past 5Y = 47.03% Sales Q/Q = 43.91% ROA = 48.01% ROE = 127.46%

EXCLUSIVE OFFER: Jim Cramer’s Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he’s trading today with a 14-day FREE pass.

4. Pharmacyclics Inc. (PCYC): Operates as a clinical-stage biopharmaceutical company focusing on developing and commercializing small-molecule drugs for the treatment of immune mediated disease and cancer. Market cap at $4.38B, most recent closing price at $62.70.Sales past 5Y = 265.32% Sales Q/Q = 277454.10% ROA = 49.27% ROE = 66.49%

5. Tesoro Logistics LP (TLLP): Operates, develops, and acquires assets involving oil and petroleum products. Market cap at $1.62B, most recent closing price at $45.0.Sales past 5Y = 31.06% Sales Q/Q = 53.56% ROA = 22.82% ROE = 357.64%

(By Kaptiall’s Nick Sousa)

 

null